Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) was down 3.8% on Monday . The stock traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares were traded during trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Price Performance
The company has a market cap of C$52.28 million and a PE ratio of -0.37. The company has a debt-to-equity ratio of 35.45, a current ratio of 2.97 and a quick ratio of 2.61. The stock has a fifty day moving average price of C$0.26 and a 200-day moving average price of C$0.26.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Read More
- Five stocks we like better than Emerald Health Therapeutics
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- How to Capture the Benefits of Dividend Increases
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
